Featured Products

My Quote Request

No products added yet

6505-01-291-4865

20 Products

S1260-10

DEXTROSE INJECTION,USP

NSN, MFG P/N

6505012914865

NSN

6505-01-291-4865

View More Info

S1260-10

DEXTROSE INJECTION,USP

NSN, MFG P/N

6505012914865

NSN

6505-01-291-4865

MFG

B BRAUN MEDICAL INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BOTTLE WITH A RATED CAPACITY OF 1000 ML.
TOTAL PRIMARY CONTAINER QUANTITY: 6

NDC51039-0605-05

PROTAMINE SULFATE INJECTION,USP

NSN, MFG P/N

6505012907654

NSN

6505-01-290-7654

View More Info

NDC51039-0605-05

PROTAMINE SULFATE INJECTION,USP

NSN, MFG P/N

6505012907654

NSN

6505-01-290-7654

MFG

U S DEPT OF VETERANS AFFAIRS

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PROTAMINE SULFATE PER 5 MILLILITERS
ADMINISTRATION: INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 5

NDC00469-3202-25

LIDOCAINE HYDROCHLORIDE INJECTION,USP

NSN, MFG P/N

6505012907655

NSN

6505-01-290-7655

View More Info

NDC00469-3202-25

LIDOCAINE HYDROCHLORIDE INJECTION,USP

NSN, MFG P/N

6505012907655

NSN

6505-01-290-7655

MFG

LYPHOMED INC DIV OF FUJISAWA USA INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS LIDOCAINE HYDROCHLORIDE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: PACKAGE
TOTAL PRIMARY CONTAINER QUANTITY: 25

NDC00074-4552-19

LEVOTHYROXINE SODIUM TABLETS,USP

NSN, MFG P/N

6505012908735

NSN

6505-01-290-8735

View More Info

NDC00074-4552-19

LEVOTHYROXINE SODIUM TABLETS,USP

NSN, MFG P/N

6505012908735

NSN

6505-01-290-8735

MFG

ABBOTT LABORATORIES DIAGNOSTICS DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.050 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
DESIGN CONTROL REFERENCE: NDC00074-4552-19
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOTHYROXINE SODIUM TABLETS USP 0.050MG 1000S BT
MANUFACTURERS CODE: 4W445
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SOLE SOURCE ITEM FOR DOD, SYNTHROID BY BOOTS
THE MANUFACTURERS DATA:

SYNTHROID

LEVOTHYROXINE SODIUM TABLETS,USP

NSN, MFG P/N

6505012908735

NSN

6505-01-290-8735

View More Info

SYNTHROID

LEVOTHYROXINE SODIUM TABLETS,USP

NSN, MFG P/N

6505012908735

NSN

6505-01-290-8735

MFG

ABBOTT LABORATORIES DIAGNOSTICS DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.050 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
DESIGN CONTROL REFERENCE: NDC00074-4552-19
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOTHYROXINE SODIUM TABLETS USP 0.050MG 1000S BT
MANUFACTURERS CODE: 4W445
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SOLE SOURCE ITEM FOR DOD, SYNTHROID BY BOOTS
THE MANUFACTURERS DATA:

NDC00062-5350-01

TERCONAZOLE VAGINAL CREAM

NSN, MFG P/N

6505012908950

NSN

6505-01-290-8950

View More Info

NDC00062-5350-01

TERCONAZOLE VAGINAL CREAM

NSN, MFG P/N

6505012908950

NSN

6505-01-290-8950

MFG

ORTHO PHARMACEUTICAL CORP OMNI EDUCATION DIV SUB OF JOHNSON AND JOHNSON

Description

ACTIVE INGREDIENT AND STRENGTH: 0.400 TERCONAZOLE PERCENTAGE, W/W
ADMINISTRATION: VAGINAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TERCONAZOLE VAGINAL CREAM 0.4% 45GM TUBE W/DOSE APPLICATOR
PRIMARY CONTAINER CONTENT QUANTITY: 45.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: WITH MEASURED DOSE APPLICATOR
TOTAL PRIMARY CONTAINER QUANTITY: 1

NDC00168-0346-46

TERCONAZOLE VAGINAL CREAM

NSN, MFG P/N

6505012908950

NSN

6505-01-290-8950

View More Info

NDC00168-0346-46

TERCONAZOLE VAGINAL CREAM

NSN, MFG P/N

6505012908950

NSN

6505-01-290-8950

MFG

NYCOMED US INC. DIV FOUGERA/SAVAGE LABS/PHARMADERM

Description

ACTIVE INGREDIENT AND STRENGTH: 0.400 TERCONAZOLE PERCENTAGE, W/W
ADMINISTRATION: VAGINAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TERCONAZOLE VAGINAL CREAM 0.4% 45GM TUBE W/DOSE APPLICATOR
PRIMARY CONTAINER CONTENT QUANTITY: 45.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: WITH MEASURED DOSE APPLICATOR
TOTAL PRIMARY CONTAINER QUANTITY: 1

NDC51672-1304-06

TERCONAZOLE VAGINAL CREAM

NSN, MFG P/N

6505012908950

NSN

6505-01-290-8950

View More Info

NDC51672-1304-06

TERCONAZOLE VAGINAL CREAM

NSN, MFG P/N

6505012908950

NSN

6505-01-290-8950

MFG

TARO PHARMACEUTICALS U.S.A. INC.

Description

ACTIVE INGREDIENT AND STRENGTH: 0.400 TERCONAZOLE PERCENTAGE, W/W
ADMINISTRATION: VAGINAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TERCONAZOLE VAGINAL CREAM 0.4% 45GM TUBE W/DOSE APPLICATOR
PRIMARY CONTAINER CONTENT QUANTITY: 45.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: WITH MEASURED DOSE APPLICATOR
TOTAL PRIMARY CONTAINER QUANTITY: 1

TERAZOL 7

TERCONAZOLE VAGINAL CREAM

NSN, MFG P/N

6505012908950

NSN

6505-01-290-8950

View More Info

TERAZOL 7

TERCONAZOLE VAGINAL CREAM

NSN, MFG P/N

6505012908950

NSN

6505-01-290-8950

MFG

ORTHO PHARMACEUTICAL CORP OMNI EDUCATION DIV SUB OF JOHNSON AND JOHNSON

Description

ACTIVE INGREDIENT AND STRENGTH: 0.400 TERCONAZOLE PERCENTAGE, W/W
ADMINISTRATION: VAGINAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TERCONAZOLE VAGINAL CREAM 0.4% 45GM TUBE W/DOSE APPLICATOR
PRIMARY CONTAINER CONTENT QUANTITY: 45.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: WITH MEASURED DOSE APPLICATOR
TOTAL PRIMARY CONTAINER QUANTITY: 1

NDC00182-0475-10

CHLORPROMAZINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505012910332

NSN

6505-01-291-0332

View More Info

NDC00182-0475-10

CHLORPROMAZINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505012910332

NSN

6505-01-291-0332

MFG

GOLDLINE LABORATORIES GOVERNMENT SALES DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS CHLOROPYRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00536-4915-10

CHLORPROMAZINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505012910332

NSN

6505-01-291-0332

View More Info

NDC00536-4915-10

CHLORPROMAZINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505012910332

NSN

6505-01-291-0332

MFG

RUGBY GROUP INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS CHLOROPYRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

01-0106

SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505012910333

NSN

6505-01-291-0333

View More Info

01-0106

SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505012910333

NSN

6505-01-291-0333

MFG

DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.000 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INJECTION USP 500ML PLASTIC BAG 24S
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: VIAFLEX PLASTIC CONTAINER, AVOID EXCESSIVE HEAT; RECOMMEND THE PRODUCT BE STORED AT ROOM TEMP, 25 DEG C; BRIEF EXPOSURE UP TO 40 DEG C DOES NOT ADVERSELY AFFECT THE PRODUCT
TOTAL PRIMARY CONTAINER QUANTITY: 24

2B1353Q

SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505012910333

NSN

6505-01-291-0333

View More Info

2B1353Q

SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505012910333

NSN

6505-01-291-0333

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.000 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INJECTION USP 500ML PLASTIC BAG 24S
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: VIAFLEX PLASTIC CONTAINER, AVOID EXCESSIVE HEAT; RECOMMEND THE PRODUCT BE STORED AT ROOM TEMP, 25 DEG C; BRIEF EXPOSURE UP TO 40 DEG C DOES NOT ADVERSELY AFFECT THE PRODUCT
TOTAL PRIMARY CONTAINER QUANTITY: 24

NDC00338-0054-03

SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505012910333

NSN

6505-01-291-0333

View More Info

NDC00338-0054-03

SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505012910333

NSN

6505-01-291-0333

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.000 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INJECTION USP 500ML PLASTIC BAG 24S
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: VIAFLEX PLASTIC CONTAINER, AVOID EXCESSIVE HEAT; RECOMMEND THE PRODUCT BE STORED AT ROOM TEMP, 25 DEG C; BRIEF EXPOSURE UP TO 40 DEG C DOES NOT ADVERSELY AFFECT THE PRODUCT
TOTAL PRIMARY CONTAINER QUANTITY: 24

D5581

THEOPHYLLINE AND DEXTROSE INJECTION

NSN, MFG P/N

6505012911117

NSN

6505-01-291-1117

View More Info

D5581

THEOPHYLLINE AND DEXTROSE INJECTION

NSN, MFG P/N

6505012911117

NSN

6505-01-291-1117

MFG

B BRAUN MEDICAL INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 800.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT AND 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 10
UNIT PACKAGE TYPE: PACKAGE

NDC00264-5558-10

THEOPHYLLINE AND DEXTROSE INJECTION

NSN, MFG P/N

6505012911117

NSN

6505-01-291-1117

View More Info

NDC00264-5558-10

THEOPHYLLINE AND DEXTROSE INJECTION

NSN, MFG P/N

6505012911117

NSN

6505-01-291-1117

MFG

B BRAUN MEDICAL INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 800.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT AND 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 10
UNIT PACKAGE TYPE: PACKAGE

NDC00074-6145-02

UROKINASE FOR CATHETER CLEARANCE

NSN, MFG P/N

6505012912646

NSN

6505-01-291-2646

View More Info

NDC00074-6145-02

UROKINASE FOR CATHETER CLEARANCE

NSN, MFG P/N

6505012912646

NSN

6505-01-291-2646

MFG

ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS GELATIN PER MILLILITER OF RECONSTITUTED SOLUTION AND 15.000 MILLIGRAMS MANNITOL PER MILLILITER OF RECONSTITUTED SOLUTION AND 7.000 MILLIGRAMS SODIUM CHLORIDE PER MILLILITER OF RECONSTITUTED SOLUTION AND 4.600 MILLIGRAMS SODIUM PHOSPHATE,
FEATURES PROVIDED: DILUENT AND STERILE
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.800 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: VIAL
~1: MONOBASIC, ANHYDROUS PER MILLILITER OF RECONSTITUTED SOLUTION AND 5000.000 INTERNATIONAL UNITS UROKINASE PER MILLILITER OF RECONSTITUTED SOLUTION

NDC00085-0933-81

THEOPHYLLINE EXTENDED-RELEASE TABLETS

NSN, MFG P/N

6505012912657

NSN

6505-01-291-2657

View More Info

NDC00085-0933-81

THEOPHYLLINE EXTENDED-RELEASE TABLETS

NSN, MFG P/N

6505012912657

NSN

6505-01-291-2657

MFG

SCHERING LABORATORIES INSTITUTIONAL SALES DEPT K-11-3 L-5

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: LONG ACTION METHOD:EXTENDED RELEASE;

THEO-DUR

THEOPHYLLINE EXTENDED-RELEASE TABLETS

NSN, MFG P/N

6505012912657

NSN

6505-01-291-2657

View More Info

THEO-DUR

THEOPHYLLINE EXTENDED-RELEASE TABLETS

NSN, MFG P/N

6505012912657

NSN

6505-01-291-2657

MFG

SCHERING LABORATORIES INSTITUTIONAL SALES DEPT K-11-3 L-5

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: LONG ACTION METHOD:EXTENDED RELEASE;

NDC00264-1126-01

DEXTROSE INJECTION,USP

NSN, MFG P/N

6505012914865

NSN

6505-01-291-4865

View More Info

NDC00264-1126-01

DEXTROSE INJECTION,USP

NSN, MFG P/N

6505012914865

NSN

6505-01-291-4865

MFG

B BRAUN MEDICAL INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BOTTLE WITH A RATED CAPACITY OF 1000 ML.
TOTAL PRIMARY CONTAINER QUANTITY: 6